Development of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia

Nicole A. Braun, Yanice V. Mendez-Fernandez, Roman Covarrubias, Steven A. Porcelli, Paul B. Savage, Hideo Yagita, Luc Van Kaer, Amy S. Major

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective: In this study, we investigated whether dyslipidemia-associated perturbed invariant natural killer T (iNKT) cell function is due to intrinsic changes in iNKT cells or defects in the ability of antigen-presenting cells to activate iNKT cells. Methods and Results: We compared iNKT cell expansion and cytokine production in C57BL/6J (B6) and apolipoprotein E-deficient (apoE -/-) mice. In response to in vivo stimulation with α-galactosylceramide, a prototypic iNKT cell glycolipid antigen, apoE -/- mice showed significantly decreased splenic iNKT cell expansion at 3 days after injection, a profile associated with iNKT cell anergy due to chronic stimulation. This decrease in expansion and cytokine production was accompanied by a 2-fold increase in percentage of iNKT cells expressing the inhibitory marker programmed death-1 in apoE-/- mice compared with controls. However, in vivo and in vitro blockade of programmed death-1 using monoclonal antibody was not able to restore functions of iNKT cells from apoE-/- mice to B6 levels. iNKT cells from apoE-/- mice also had increased intracellular T cell receptor and Ly49 expression, a phenotype associated with previous activation. Changes in iNKT cell functions were cell autonomous, because dendritic cells from apoE-/- mice were able to activate B6 iNKT cells, but iNKT cells from apoE-/- mice were not able to respond to B6 dendritic cells. Conclusion: These data suggest that chronic dyslipidemia induces an iNKT cell phenotype that is unresponsive to further simulation by exogenous glycolipid and that sustained unresponsiveness is iNKT cell intrinsic.

Original languageEnglish (US)
Pages (from-to)1758-1765
Number of pages8
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume30
Issue number9
DOIs
StatePublished - Sep 2010

Fingerprint

Natural Killer T-Cells
Dyslipidemias
Apolipoproteins E
Glycolipids
Dendritic Cells
Galactosylceramides
Cytokines
Phenotype
Antigen-Presenting Cells
T-Cell Antigen Receptor

Keywords

  • antigen
  • hypercholesterolemia
  • immunology
  • lipid
  • lymphocytes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Development of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia. / Braun, Nicole A.; Mendez-Fernandez, Yanice V.; Covarrubias, Roman; Porcelli, Steven A.; Savage, Paul B.; Yagita, Hideo; Van Kaer, Luc; Major, Amy S.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 30, No. 9, 09.2010, p. 1758-1765.

Research output: Contribution to journalArticle

Braun, NA, Mendez-Fernandez, YV, Covarrubias, R, Porcelli, SA, Savage, PB, Yagita, H, Van Kaer, L & Major, AS 2010, 'Development of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 9, pp. 1758-1765. https://doi.org/10.1161/ATVBAHA.110.206045
Braun, Nicole A. ; Mendez-Fernandez, Yanice V. ; Covarrubias, Roman ; Porcelli, Steven A. ; Savage, Paul B. ; Yagita, Hideo ; Van Kaer, Luc ; Major, Amy S. / Development of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2010 ; Vol. 30, No. 9. pp. 1758-1765.
@article{240868d130b54f68aad3aa33de02538c,
title = "Development of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia",
abstract = "Objective: In this study, we investigated whether dyslipidemia-associated perturbed invariant natural killer T (iNKT) cell function is due to intrinsic changes in iNKT cells or defects in the ability of antigen-presenting cells to activate iNKT cells. Methods and Results: We compared iNKT cell expansion and cytokine production in C57BL/6J (B6) and apolipoprotein E-deficient (apoE -/-) mice. In response to in vivo stimulation with α-galactosylceramide, a prototypic iNKT cell glycolipid antigen, apoE -/- mice showed significantly decreased splenic iNKT cell expansion at 3 days after injection, a profile associated with iNKT cell anergy due to chronic stimulation. This decrease in expansion and cytokine production was accompanied by a 2-fold increase in percentage of iNKT cells expressing the inhibitory marker programmed death-1 in apoE-/- mice compared with controls. However, in vivo and in vitro blockade of programmed death-1 using monoclonal antibody was not able to restore functions of iNKT cells from apoE-/- mice to B6 levels. iNKT cells from apoE-/- mice also had increased intracellular T cell receptor and Ly49 expression, a phenotype associated with previous activation. Changes in iNKT cell functions were cell autonomous, because dendritic cells from apoE-/- mice were able to activate B6 iNKT cells, but iNKT cells from apoE-/- mice were not able to respond to B6 dendritic cells. Conclusion: These data suggest that chronic dyslipidemia induces an iNKT cell phenotype that is unresponsive to further simulation by exogenous glycolipid and that sustained unresponsiveness is iNKT cell intrinsic.",
keywords = "antigen, hypercholesterolemia, immunology, lipid, lymphocytes",
author = "Braun, {Nicole A.} and Mendez-Fernandez, {Yanice V.} and Roman Covarrubias and Porcelli, {Steven A.} and Savage, {Paul B.} and Hideo Yagita and {Van Kaer}, Luc and Major, {Amy S.}",
year = "2010",
month = "9",
doi = "10.1161/ATVBAHA.110.206045",
language = "English (US)",
volume = "30",
pages = "1758--1765",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Development of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia

AU - Braun, Nicole A.

AU - Mendez-Fernandez, Yanice V.

AU - Covarrubias, Roman

AU - Porcelli, Steven A.

AU - Savage, Paul B.

AU - Yagita, Hideo

AU - Van Kaer, Luc

AU - Major, Amy S.

PY - 2010/9

Y1 - 2010/9

N2 - Objective: In this study, we investigated whether dyslipidemia-associated perturbed invariant natural killer T (iNKT) cell function is due to intrinsic changes in iNKT cells or defects in the ability of antigen-presenting cells to activate iNKT cells. Methods and Results: We compared iNKT cell expansion and cytokine production in C57BL/6J (B6) and apolipoprotein E-deficient (apoE -/-) mice. In response to in vivo stimulation with α-galactosylceramide, a prototypic iNKT cell glycolipid antigen, apoE -/- mice showed significantly decreased splenic iNKT cell expansion at 3 days after injection, a profile associated with iNKT cell anergy due to chronic stimulation. This decrease in expansion and cytokine production was accompanied by a 2-fold increase in percentage of iNKT cells expressing the inhibitory marker programmed death-1 in apoE-/- mice compared with controls. However, in vivo and in vitro blockade of programmed death-1 using monoclonal antibody was not able to restore functions of iNKT cells from apoE-/- mice to B6 levels. iNKT cells from apoE-/- mice also had increased intracellular T cell receptor and Ly49 expression, a phenotype associated with previous activation. Changes in iNKT cell functions were cell autonomous, because dendritic cells from apoE-/- mice were able to activate B6 iNKT cells, but iNKT cells from apoE-/- mice were not able to respond to B6 dendritic cells. Conclusion: These data suggest that chronic dyslipidemia induces an iNKT cell phenotype that is unresponsive to further simulation by exogenous glycolipid and that sustained unresponsiveness is iNKT cell intrinsic.

AB - Objective: In this study, we investigated whether dyslipidemia-associated perturbed invariant natural killer T (iNKT) cell function is due to intrinsic changes in iNKT cells or defects in the ability of antigen-presenting cells to activate iNKT cells. Methods and Results: We compared iNKT cell expansion and cytokine production in C57BL/6J (B6) and apolipoprotein E-deficient (apoE -/-) mice. In response to in vivo stimulation with α-galactosylceramide, a prototypic iNKT cell glycolipid antigen, apoE -/- mice showed significantly decreased splenic iNKT cell expansion at 3 days after injection, a profile associated with iNKT cell anergy due to chronic stimulation. This decrease in expansion and cytokine production was accompanied by a 2-fold increase in percentage of iNKT cells expressing the inhibitory marker programmed death-1 in apoE-/- mice compared with controls. However, in vivo and in vitro blockade of programmed death-1 using monoclonal antibody was not able to restore functions of iNKT cells from apoE-/- mice to B6 levels. iNKT cells from apoE-/- mice also had increased intracellular T cell receptor and Ly49 expression, a phenotype associated with previous activation. Changes in iNKT cell functions were cell autonomous, because dendritic cells from apoE-/- mice were able to activate B6 iNKT cells, but iNKT cells from apoE-/- mice were not able to respond to B6 dendritic cells. Conclusion: These data suggest that chronic dyslipidemia induces an iNKT cell phenotype that is unresponsive to further simulation by exogenous glycolipid and that sustained unresponsiveness is iNKT cell intrinsic.

KW - antigen

KW - hypercholesterolemia

KW - immunology

KW - lipid

KW - lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=77955984247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955984247&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.110.206045

DO - 10.1161/ATVBAHA.110.206045

M3 - Article

C2 - 20539017

AN - SCOPUS:77955984247

VL - 30

SP - 1758

EP - 1765

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 9

ER -